Skip to main content
. 2015 Nov 19;19(2):188–197. doi: 10.3109/13697137.2015.1107039

Figure 5.

Figure 5.

Proportion of participants concerned with long-term use of their current vulvovaginal atrophy medication. OTC, over the counter.